Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (621-630 of 777) with videos related to

Pageof 78
Sort By:
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
Risk of portal hypertensive complications preventable by TIPS in patients with ascitesLorenz Balcar, Marta Tonon, Joan Valls, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasisLeander Blaas, Jan-Wilhelm Kornfeld, Daniel Schramek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLDLorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Wiener Klinische Wochenschrift|September 4, 2025
Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary centerMarlene Hintersteininger, Julia Kappel, Theresa Müllner-Buscics, et al.
Journal of Hepatology|October 2, 2024
Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in miceEmmanuel Dauda Dixon, Thierry Claudel, Alexander Daniel Nardo, et al.
Cell Death Discovery|August 2, 2023
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosisKatharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
Journal of Hepatology|August 31, 2025
Erratum to 'Inhibition of ATGL alleviates MASH via impaired PPARa signalling that favours hydrophilic bile acid composition in mice' [J Hepatol 82 (2025) 658-675]Emmanuel Dauda Dixon, Thierry Claudel, Alexander Daniel Nardo, et al.
Pageof 78

Showing results (621-630 of 777) with videos related to

Sort By:
Pageof 78
Alimentary Pharmacology & Therapeutics|May 6, 2022
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" studyMathias Jachs, Caroline Schwarz, Marlene Panzer, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
Risk of portal hypertensive complications preventable by TIPS in patients with ascitesLorenz Balcar, Marta Tonon, Joan Valls, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasisLeander Blaas, Jan-Wilhelm Kornfeld, Daniel Schramek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2025
Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLDLorenz Balcar, Bernhard Scheiner, Benedikt Simbrunner, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Wiener Klinische Wochenschrift|September 4, 2025
Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary centerMarlene Hintersteininger, Julia Kappel, Theresa Müllner-Buscics, et al.
Journal of Hepatology|October 2, 2024
Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in miceEmmanuel Dauda Dixon, Thierry Claudel, Alexander Daniel Nardo, et al.
Cell Death Discovery|August 2, 2023
Gas6 in chronic liver disease-a novel blood-based biomarker for liver fibrosisKatharina Staufer, Heidemarie Huber, Jasmin Zessner-Spitzenberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
Journal of Hepatology|August 31, 2025
Erratum to 'Inhibition of ATGL alleviates MASH via impaired PPARa signalling that favours hydrophilic bile acid composition in mice' [J Hepatol 82 (2025) 658-675]Emmanuel Dauda Dixon, Thierry Claudel, Alexander Daniel Nardo, et al.
Pageof 78